Duloxetine (Cymbalta) combined with tramadol increases the risk of serotonin syndrome and seizures. Both drugs affect serotonin levels, and duloxetine also inhibits the enzyme needed to activate tramadol, creating a paradox of increased toxicity with decreased pain relief.
How This Interaction Works (Mechanism)
Duloxetine inhibits both serotonin and norepinephrine reuptake (SNRI), while tramadol also inhibits serotonin reuptake and weakly activates mu-opioid receptors through its active metabolite. The combined serotonergic effect creates risk of serotonin syndrome. Additionally, duloxetine is a potent CYP2D6 inhibitor, blocking tramadol's conversion to its active analgesic metabolite (M1). This means the combination is both more dangerous (serotonin toxicity) and less effective (reduced pain relief).
Source: Cymbalta (Duloxetine) Prescribing Information, Eli Lilly, 2025
Avoid this combination when possible. If pain management is needed while taking duloxetine, consider non-serotonergic alternatives such as acetaminophen, NSAIDs (with appropriate GI precautions), or a different opioid that does not affect serotonin. If the combination is unavoidable, use the lowest effective doses and monitor for serotonin syndrome: agitation, confusion, rapid heart rate, dilated pupils, and muscle twitching. Seek emergency care if symptoms develop.
Check More Drug Interactions
Use our free interaction checker to search thousands of drug, supplement, and food combinations.
Open Interaction CheckerKeep a multi-drug routine straight
As an Amazon Associate I earn from qualifying purchases.
Sources and standards behind this page
What a drug interaction does, and how strongly it is supported, is documented in public labeling and federal safety references rather than in any one summary, and the sources below are the primary ones. They are linked so a reader can check a claim without taking this page's word for it.
- DailyMed carries the current FDA labeling for every marketed drug product, including the warnings and drug interaction sections.
- Drugs@FDA is the federal database of approved drug products and their approval documents.
- FDA: Drug interactions, what you should know explains how drug-drug, drug-food and drug-condition interactions are described on labels.
- FDA Drug Safety Communications publishes the agency's safety alerts and label changes as they are issued.
- FDA MedWatch is the program for reporting and reviewing adverse events, including suspected interactions.
- openFDA provides public access to FDA labeling and adverse event data.
- MedlinePlus drug information is the National Library of Medicine's consumer reference for what a medicine is and how it is taken.
- NIAAA: Harmful interactions documents which medicines interact with alcohol and how.
- NCCIH: Herb-drug interactions summarises the evidence on interactions between herbal products and medicines.
- National Library of Medicine maintains the drug and health databases the sources above draw on.
This page describes how this interaction works and where it is documented. It is not medical advice: a prescriber or pharmacist decides what applies to a particular patient and medication.
Frequently Asked Questions
Duloxetine and Tramadol have a severe interaction and should generally not be taken together without close medical supervision. The combination can cause serious, potentially life-threatening side effects. Contact your doctor immediately if you are currently taking both medications.
Duloxetine (Cymbalta) combined with tramadol increases the risk of serotonin syndrome and seizures. Both drugs affect serotonin levels, and duloxetine also inhibits the enzyme needed to activate tramadol, creating a paradox of increased toxicity with decreased pain relief.
Yes. Anytime you are taking multiple medications, supplements, or substances, you should inform your doctor and pharmacist. They can evaluate your specific risk factors (age, kidney function, other medications, medical conditions) and determine whether the Duloxetine and Tramadol combination is safe for you, or whether adjustments are needed.
Related Resources
Get Drug Safety Alerts
Leave your email for updates on FDA warnings, new drug interactions, and patient safety information. We have not started sending yet, and we will only email when we do.